Resultados de la búsqueda 571-580 of 2212 for GLP-1 secretion

  1. Oncología (médica) - Ensayos clínicos

    ... release. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL ... 1 cells administered following a conditioning ... one month. Numeración de páginas Estudios ...

  2. Neurocirugía - Ensayos clínicos

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...

  3. Neurología - Ensayos clínicos

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  4. Genómica clínica - Ensayos clínicos

    The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial ...

  5. Oncología (médica) - Ensayos clínicos

    We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive the CAR TIL to ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... release. Treatment of Metastatic Soft Tissue ... In the study, 122 patients will be randomized in a 1:1 ... one year later) in subjects with high-risk multiple ...

  7. Oncología (médica) - Ensayos clínicos

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in combination ...

  8. Oncología (médica) - Ensayos clínicos

    Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

  9. Centro Pediátrico de Mayo Clinic

    The purpose of this study is to evaluate patterns of and changes in secretion levels of the stress hormone, cortisol and other steroid hormones (i.e. DHEA ...

  10. Oncología (médica) - Ensayos clínicos

    Phase 1 of this study is designed to evaluate the ... Participants in both Phase 1 ... A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in ...